TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
PYC Therapeutics Limited ( (AU:PYC) ) has shared an announcement.
PYC Therapeutics Limited has released a presentation providing an update on its business operations. The presentation emphasizes the company’s ongoing commitment to advancing its therapeutic solutions, although it advises stakeholders to consider the inherent risks and uncertainties associated with forward-looking statements.
The most recent analyst rating on (AU:PYC) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on PYC Therapeutics Limited stock, see the AU:PYC Stock Forecast page.
More about PYC Therapeutics Limited
PYC Therapeutics Limited operates in the biotechnology industry, focusing on developing therapeutic solutions. The company is listed on the Australian Securities Exchange under the ticker PYC.
Average Trading Volume: 740,360
Technical Sentiment Signal: Hold
Current Market Cap: A$670.7M
Find detailed analytics on PYC stock on TipRanks’ Stock Analysis page.